article thumbnail

Pfizer settles gender pay discrimination allegations at NYC headquarters

Fierce Pharma

The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |

286
286
article thumbnail

How high-intent platforms help pharma brands engage action-oriented customers

Fierce Pharma

Way back in 2015 a post on the Think with Google blog made the bold claim that, for marketers, consumer intent is more powerful than demographics: “Intent beats identity. GoodRx is a trusted, high-intent platform that helps providers and patients find what they need at the exact moment they are looking for something.

Pharma 242
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy

MedCity News

Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals. GSK Senior Vice President, Global Head of Oncology, R&D Hesham Abdullah explained the company’s evolving cancer strategy in an interview during the J.P.

article thumbnail

The Year in Review: Top Posts of 2015

The Brooks Group

2015 was a big year for The Brooks Group, and we’re going to brag a little. Top 7 Articles of 2015 . Our achievements this year included: Bronze Stevie Award for Sales Training Practice of the Year. Top 20 Sales Training Company, Training Industry. Top 20 Sales Training Company, Selling Power Magazine. 5000 Fastest Growing Company.

article thumbnail

Labor Department Sues UnitedHealth Group Over ‘Thousands’ of Claims Denials

MedCity News

The Labor Department recently sued UnitedHealth Group subsidiary UMR, alleging that it wrongfully denied claims for emergency room services and urinary drug screenings since 2015.

Medical 98
article thumbnail

Biosimilars: Are They Delivering the Cost Savings Promised?

Pharmacy Times

Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.

FDA 61
article thumbnail

Lung cancer deaths decline but.

World of DTC Marketing

In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017.

Insurance 271